USANA Health Sciences (USNA) Tops Q3 EPS by 10c
Get Alerts USNA Hot Sheet
Price: $43.70 -2.35%
Revenue Growth %: -9.9%
Financial Fact:
Selling, general and administrative: 60.59M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Revenue Growth %: -9.9%
Financial Fact:
Selling, general and administrative: 60.59M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.47, $0.10 better than the analyst estimate of $1.37. Revenue for the quarter came in at $191.9 million versus the consensus estimate of $190.5 million.
USANA Health Sciences sees FY2014 EPS of $5.85-$5.95, versus prior guidance of $5.5-$5.65 and the consensus of $5.53. USANA Health Sciences sees FY2014 revenue of $780-790 million, versus prior guidance of $770-790 million and the consensus of $769.5 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Kaiser Aluminum (KALU) Tops Q1 EPS by 42c
- Meta Platforms Inc. (META) PT Lowered to $500 at Goldman Sachs, 'Management Track Record of Execution Leaves Us Long-Term Constructive'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!